Senate panel advances compounding, track-and-trace bills
This article was originally published in Scrip
Executive Summary
On the same day the Senate Health, Education, Labor and Pensions (HELP) Committee adopted legislation aimed at giving the FDA more authority over compounding pharmacies, a group of bipartisan lawmakers issued a report showing that eight months after one of those firm's tainted products caused a nationwide fungal meningitis outbreak, the public remains at risk.